Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Qili Pharmaceutical is a Chinese pharmaceutical company focused on the research, development, and manufacturing of high-quality generic drugs and traditional Chinese medicines. The company operates modern production facilities that comply with GMP standards, producing a wide range of formulations including tablets, capsules, and injections. Qili Pharmaceutical's product portfolio primarily targets therapeutic areas such as gastroenterology, infectious diseases, and cardiovascular health. With a strong emphasis on quality control and technological innovation, the company serves both domestic and international markets through its integrated supply chain and distribution networks.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qili Pharma.